Skip to main content

An Open-Label, Proof of Concept Study Designed to Evaluate the Safety, Efficacy and Pharmacodynamic Effect of Bertilimumab in Patients with Newly Diagnosed, Moderate to Extensive Bullous Pemphigoid

Clinical Trial Grant
Duke Scholars

Administered By

Dermatology

Awarded By

Immune Pharmaceuticals

Start Date

July 1, 2016

End Date

June 20, 2020
 

Administered By

Dermatology

Awarded By

Immune Pharmaceuticals

Start Date

July 1, 2016

End Date

June 20, 2020